Bovie Medical Corporation Announces FDA Clearance To Market Patent Pending Suture Removal Device

MELVILLE, N.Y.--(BUSINESS WIRE)--July 25, 2006--Bovie Medical Corporation (the "Company") (Amex: BVX - News), a manufacturer and marketer of electrosurgical products, today announced that it has received U.S. Food and Drug Administration (FDA) 510(K) clearance to market its "In-a-Flash" Suture Removal device. The device is designed to remove sutures with a tension free cut and is anticipated to be utilized in various human and animal medical procedures. The Company plans to market and distribute the device through its established and growing distribution network.

Commenting on the FDA clearance to market, J. Robert Saron, president of Bovie Medical's wholly-owned subsidiary Aaron Medical, stated, "We are pleased with the progress the Company is making developing proprietary and innovative medical technologies. We will be introducing the 'In-a-Flash' Suture Removal device at the Health Industry Distributors Association show (HIDA) in Chicago, IL. from September 19-21, 2006. The HIDA show is the largest medical distributor meeting that Bovie attends in the United States."

This document may contain some forward looking statements, particularly regarding operational prospects in 2006 and beyond, which involve a number of risks and uncertainties that could cause actual results to differ materially. These risks are listed from time to time in the Company's SEC filings.

Contact: Buttonwood Advisory Group, Inc. Investor Relations: John Aneralla, 800-940-9087

Source: Bovie Medical Corporation